Sirolimus (SRL) has been proposed to replace calcineurin inhibitors (CNI) in case of CNI-induced toxicity. The aim of this study was to evaluate the efficacy and safety of conversion from CNI to SRL in maintenance liver transplantation (LT) patients. Between 2002 and 2006, conversion was performed i
β¦ LIBER β¦
Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients
β Scribed by Aimee K Sundberg; Michael S Rohr; Erica L Hartmann; Patricia L Adams; Robert J Stratta
- Book ID
- 110889421
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 103 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0902-0063
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Conversion to sirolimus-based immunosupp
β
Isabelle Morard; JΓ©rΓ΄me Dumortier; Laurent Spahr; Antoine Hadengue; Pietro Majno
π
Article
π
2007
π
John Wiley and Sons
π
English
β 215 KB
Conversion to monotherapy maintenance im
β
R. Sinha; Y. Tse; S. D. Marks
π
Article
π
2010
π
John Wiley and Sons
π
English
β 119 KB
Safe conversion of mycophenolate mofetil
β
AMGAD E EL-AGROUDY; KHALED F EL-DAHSHAN; EHAB W WAFA; HUSSIEN A SHEASHAA; ZIAD A
π
Article
π
2009
π
John Wiley and Sons
π
English
β 138 KB
A randomized controlled trial of late co
β
Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D
π
Article
π
2007
π
John Wiley and Sons
π
English
β 307 KB
π 1 views
Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin
Evaluation of the efficacy and safety of
β
Nassim Kamar; Luc Frimat; Gilles Blancho; Philippe Wolff; Michel Delahousse; Lio
π
Article
π
2007
π
Springer
π
English
β 482 KB